Header Logo

HEIDI RUSSELL

TitleAdjunct Associate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address1102 Bates Street
Houston, TX 77030
vCardDownload vCard
    Other Positions
    TitleAdjunct Associate Professor
    InstitutionBaylor College of Medicine
    DepartmentCenter for Medical Ethics and Health Policy
    DivisionCtr for Med Ethics & Health Policy


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Serpa JA, Gemeinhardt G, Arias CA, Morgan RO, Russell H, Miao H, Ganduglia Cazaban CM. Teaching and Safety-Net Hospital Penalization in the Hospital-Acquired Condition Reduction Program. JAMA Netw Open. 2024 Feb 05; 7(2):e2356196. PMID: 38363569; PMCID: PMC10873765.
      Citations:    Fields:    Translation:Humans
    2. Russell H, Hord J, Orr CJ, Moerdler S. Child Health and the Pediatric Hematology-Oncology Workforce: 2020-2040. Pediatrics. 2024 Feb 01; 153(Suppl 2). PMID: 38299998.
      Citations: 1     Fields:    Translation:Humans
    3. Ho V, Tapaneeyakul S, Russell HV. Price Increases Versus Upcoding As Drivers Of Emergency Department Spending Increases, 2012-19. Health Aff (Millwood). 2023 08; 42(8):1119-1127. PMID: 37549336.
      Citations:    Fields:    Translation:Humans
    4. Smith HS, Ferket BS, Gelb BD, Hindorff L, Ferar KD, Norton ME, Sahin-Hodoglugil N, Slavotinek A, Lich KH, Berg JS, Russell HV. Parent-Reported Clinical Utility of Pediatric Genomic Sequencing. Pediatrics. 2023 08 01; 152(2). PMID: 37470118; PMCID: PMC10812387.
      Citations: 1     Fields:    Translation:Humans
    5. Russell H, Smith HS, Bensen JT, Murali P, Ferket BS, Finnila C, Hindorff LA, Sahin-Hodoglugil N. Lessons learned while starting multi-institutional genetics research in diverse populations: A report from the Clinical Sequencing Evidence-Generating Research (CSER) consortium. Contemp Clin Trials. 2023 Feb; 125:107063. PMID: 36567057; PMCID: PMC9918690.
      Citations:    Fields:    
    6. Kraft SA, Russell H, Bensen JT, Bonini KE, Robinson JO, Sahin-Hodoglugil N, Renna K, Hindorff LA, Kaufman D, Horowitz CR, Waltz M, Zepp JM, Knight SJ. Conducting clinical genomics research during the COVID-19 pandemic: Lessons learned from the CSER consortium experience. Am J Med Genet A. 2023 02; 191(2):391-399. PMID: 36341765; PMCID: PMC9839535.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    7. Ferket BS, Baldwin Z, Murali P, Pai A, Mittendorf KF, Russell HV, Chen F, Lynch FL, Lich KH, Hindorff LA, Savich R, Slavotinek A, Smith HS, Gelb BD, Veenstra DL. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods. Genet Med. 2022 10; 24(10):2014-2027. PMID: 35833928; PMCID: PMC9997042.
      Citations:    Fields:    
    8. Synhorst DC, Hall M, Macy ML, Bettenhausen JL, Markham JL, Shah SS, Moretti A, Raval MV, Tian Y, Russell H, Hartley J, Morse R, Gay JC. Financial Implications of Short Stay Pediatric Hospitalizations. Pediatrics. 2022 04 01; 149(4). PMID: 35355068.
      Citations:    Fields:    Translation:Humans
    9. Fetzko S, Fonseca A, Frances Wedekind M, Gupta AA, Setty BA, Schraw J, Lupo PJ, Guillerman RP, Butala AA, Russell H, Nicholls L, Walterhouse D, Hawkins DS, Okcu MF. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma? J Pediatr Hematol Oncol. 2022 08 01; 44(6):305-312. PMID: 35137727; PMCID: PMC10026693.
      Citations: 1     Fields:    Translation:Humans
    10. Phillips KA, Trosman JR, Douglas MP, Gelb BD, Ferket BS, Hindorff LA, Slavotinek AM, Berg JS, Russell HV, Devine B, Greve V, Smith HS. US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER). Genet Med. 2022 01; 24(1):238-244. PMID: 34906461; PMCID: PMC8962136.
      Citations:    Fields:    Translation:HumansCells
    11. Russell HV, Chi YY, Okcu MF, Bernhardt MB, Rodriguez-Galindo C, Gupta AA, Hawkins DS. Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2022 Jan 15; 128(2):317-325. PMID: 34623638; PMCID: PMC8738099.
      Citations:    Fields:    Translation:Humans
    12. Weiss BD, Yanik G, Naranjo A, Zhang FF, Fitzgerald W, Shulkin BL, Parisi MT, Russell H, Grupp S, Pater L, Mattei P, Mosse Y, Lai HA, Jarzembowski JA, Shimada H, Villablanca JG, Giller R, Bagatell R, Park JR, Matthay KK. A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study. Pediatr Blood Cancer. 2021 10; 68(10):e29117. PMID: 34028986; PMCID: PMC9150928.
      Citations: 3     Fields:    Translation:Humans
    13. Russell H, Hall M, Morse RB, Cutler GJ, Macy M, Bettenhausen JL, Lopez MA, Shah SS, Sills MR. Longitudinal Trends in Costs for Hospitalizations at Children's Hospitals. Hosp Pediatr. 2020 09; 10(9):797-801. PMID: 32747333.
      Citations:    Fields:    Translation:Humans
    14. Whittle SB, Smith V, Silverstein A, Parmeter M, Minard CG, Bernhardt MB, Zage PE, Venkatramani R, Nuchtern JG, Heczey A, Russell HV, Shohet JM, Foster JH. Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417. PMID: 32729196; PMCID: PMC7722106.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    15. Smith HS, Swint JM, Lalani SR, de Oliveira Otto MC, Yamal JM, Russell HV, Lee BH. Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditions. Genet Med. 2020 08; 22(8):1303-1310. PMID: 32336750.
      Citations: 4     Fields:    Translation:Humans
    16. Lopez MA, Hall M, Auger KA, Bettenhausen JL, Colvin JD, Cutler GJ, Fieldston E, Macy ML, Morse R, Raphael JL, Russell H, Shah SS, Sills MR. Care of Pediatric High-Cost Hospitalizations Across Hospital Types. Hosp Pediatr. 2020 03; 10(3):206-213. PMID: 32024665.
      Citations: 2     Fields:    Translation:Humans
    17. Silverstein A, Reddy K, Smith V, Foster JH, Russell HV, Whittle SB. Blood product administration during high risk neuroblastoma therapy. Pediatr Hematol Oncol. 2020 Feb; 37(1):5-14. PMID: 31829069; PMCID: PMC6942619.
      Citations:    Fields:    Translation:Humans
    18. Abrams HR, Leeds HS, Russell HV, Hellsten MB. Factors Influencing Family Burden in Pediatric Hematology/Oncology Encounters. J Patient Cent Res Rev. 2019; 6(4):243-251. PMID: 31768403; PMCID: PMC6827845.
      Citations: 2     
    19. Stevens Smith H, Russell HV, Lee BH, Morain SR, and the Value of Exome Sequencing Delphi Panel. Using the Delphi method to identify clinicians' perceived importance of pediatric exome sequencing results. Genet Med. 2020 01; 22(1):69-76. PMID: 31273346.
      Citations: 4     Fields:    Translation:Humans
    20. Whittle SB, Lopez MA, Russell HV. Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations. Pediatr Blood Cancer. 2019 07; 66(7):e27739. PMID: 30989762; PMCID: PMC7057732.
      Citations: 2     Fields:    Translation:Humans
    21. Rainusso N, Seghers V, Egler R, Hicks J, Russell HV. Neuroblastoma of the Bone and Bone Marrow Without an Apparent Primary Site: Report of 4 Cases With Long-term Follow-up. Pediatr Dev Pathol. 2019 Jul-Aug; 22(4):329-333. PMID: 30600764.
      Citations: 1     Fields:    Translation:Humans
    22. Russell HV. Asparaginase products in upfront acute lymphoblastic leukemia therapy: Value, location, and style. Pediatr Blood Cancer. 2019 01; 66(1):e27497. PMID: 30318846.
      Citations:    Fields:    Translation:HumansCells
    23. Bavle A, Grimes A, Zhao S, Zinn D, Jackson A, Patel B, Porea T, Dutta A, Russell H, Heczey A. Cost-effectiveness and Improved Parent and Provider Satisfaction With Outpatient Management of Pediatric Oncology Patients, With Low-risk Fever and Neutropenia. J Pediatr Hematol Oncol. 2018 10; 40(7):e415-e420. PMID: 29334532.
      Citations:    Fields:    Translation:Humans
    24. Kaul S, Russell H, Livingston JA, Kirchhoff AC, Jupiter D. Emergency Department Visits by Adolescent and Young Adult Cancer Patients Compared with Pediatric Cancer Patients in the United States. J Adolesc Young Adult Oncol. 2018 10; 7(5):553-564. PMID: 29924663; PMCID: PMC6909771.
      Citations: 2     Fields:    Translation:Humans
    25. Smith HS, Swint JM, Lalani SR, Yamal JM, de Oliveira Otto MC, Castellanos S, Taylor A, Lee BH, Russell HV. Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature. Genet Med. 2019 01; 21(1):3-16. PMID: 29760485.
      Citations: 31     Fields:    Translation:Humans
    26. Scheurer ME, Lupo PJ, Spector LG, Wiemels JL, Aplenc R, Gramatges MM, Schiffman JD, Yang JJ, Heck JE, Metayer C, Orjuela-Grimm MA, Bona K, Aristizabal P, Austin MT, Rabin KR, Russell HV, Poplack DG, Sch?z J, Pombo-de-Oliveira MS. An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018 Mar; 35(2):95-110. PMID: 29737912; PMCID: PMC6685736.
      Citations: 9     Fields:    Translation:Humans
    27. Whittle SB, Williamson KC, Russell HV. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma. Pediatr Hematol Oncol. 2017 Aug; 34(5):331-342. PMID: 29200325; PMCID: PMC7185719.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    28. Kaul S, Avila JC, Mutambudzi M, Russell H, Kirchhoff AC, Schwartz CL. Mental distress and health care use among survivors of adolescent and young adult cancer: A cross-sectional analysis of the National Health Interview Survey. Cancer. 2017 03 01; 123(5):869-878. PMID: 27859009.
      Citations: 21     Fields:    Translation:Humans
    29. Russell HV, Bernhardt MB, Berg S. Using decision modeling to guide drug allocation during a shortage. Pediatr Blood Cancer. 2017 Jul; 64(7). PMID: 27862980.
      Citations: 2     Fields:    Translation:Humans
    30. Egler RA, Gosiengfiao Y, Russell H, Wickiser JE, Frazier AL. Is surgical resection and observation sufficient for stage I and II sacrococcygeal germ cell tumors? A case series and review. Pediatr Blood Cancer. 2017 05; 64(5). PMID: 27786428.
      Citations:    Fields:    Translation:Humans
    31. Russell H, Bernhardt MB. Bending the Cost Curve in Childhood Cancer. Curr Hematol Malig Rep. 2016 08; 11(4):295-302. PMID: 27193602.
      Citations: 5     Fields:    Translation:Humans
    32. Rojas Y, Jaramillo S, Lyons K, Mahmood N, Wu MF, Liu H, Vasudevan SA, Guillerman RP, Louis CU, Russell HV, Nuchtern JG, Kim ES. The optimal timing of surgical resection in high-risk neuroblastoma. J Pediatr Surg. 2016 Oct; 51(10):1665-9. PMID: 27318861.
      Citations: 5     Fields:    Translation:Humans
    33. Russell H, Street A, Ho V. How Well Do All Patient Refined-Diagnosis-Related Groups Explain Costs of Pediatric Cancer Chemotherapy Admissions in the United States? J Oncol Pract. 2016 05; 12(5):e564-75. PMID: 27118158; PMCID: PMC5015448.
      Citations: 1     Fields:    Translation:Humans
    34. Lin JL, Guillerman RP, Russell HV, Lupo PJ, Nicholls L, Okcu MF. Does Routine Imaging of Patients for Progression or Relapse Improve Survival in Rhabdomyosarcoma? Pediatr Blood Cancer. 2016 Feb; 63(2):202-5. PMID: 26376023.
      Citations: 8     Fields:    Translation:Humans
    35. Beaty RS, Bernhardt MB, Berger AH, Hesselgrave JE, Russell HV, Okcu MF. Inpatient versus outpatient vincristine, dactinomycin, and cyclophosphamide for pediatric cancers: Quality and cost implications. Pediatr Blood Cancer. 2015 Nov; 62(11):1925-8. PMID: 26152314.
      Citations: 4     Fields:    Translation:Humans
    36. Blumenthal-Barby JS, Robinson E, Cantor SB, Naik AD, Russell HV, Volk RJ. The neglected topic: presentation of cost information in patient decision AIDS. Med Decis Making. 2015 05; 35(4):412-8. PMID: 25583552.
      Citations: 13     Fields:    Translation:Humans
    37. Russell HV, Okcu MF, Kamdar K, Shah MD, Kim E, Swint JM, Chan W, Du XL, Franzini L, Ho V. Algorithm for analysis of administrative pediatric cancer hospitalization data according to indication for admission. BMC Med Inform Decis Mak. 2014 Oct 01; 14:88. PMID: 25274165; PMCID: PMC4197316.
      Citations: 9     Fields:    Translation:Humans
    38. Mazloom A, Louis CU, Nuchtern J, Kim E, Russell H, Allen-Rhoades W, Krance R, Paulino AC. Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):858-62. PMID: 25245583; PMCID: PMC5107988.
      Citations: 18     Fields:    Translation:Humans
    39. Louis C, Hicks J, Zage P, Russell H, Aguilar S. Congenital neuroblastoma in a neonate with isotretinoin embryopathy. J Pediatr Hematol Oncol. 2014 Mar; 36(2):e75-7. PMID: 23652876.
      Citations: 1     Fields:    Translation:Humans
    40. Russell H, Swint JM, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu MF. Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2014 Jun; 61(6):970-6. PMID: 24453105; PMCID: PMC4370185.
      Citations: 6     Fields:    Translation:Humans
    41. Blumenthal-Barby JS, Cantor SB, Russell HV, Naik AD, Volk RJ. Decision aids: when 'nudging' patients to make a particular choice is more ethical than balanced, nondirective content. Health Aff (Millwood). 2013 Feb; 32(2):303-10. PMID: 23381523.
      Citations: 18     Fields:    Translation:Humans
    42. Panchal J, Vonville H, Franzini L, Swint JM, Russell HV. Economic evaluation of pediatric cancer treatment: a systematic literature review. Pediatrics. 2013 Jan; 131(1):e273-87. PMID: 23266919.
      Citations: 21     Fields:    Translation:Humans
    43. Hassan SF, Mathur S, Magliaro TJ, Larimer EL, Ferrell LB, Vasudevan SA, Patterson DM, Louis CU, Russell HV, Nuchtern JG, Kim ES. Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children. J Pediatr Surg. 2012 Jun; 47(6):1261-6. PMID: 22703803.
      Citations: 12     Fields:    Translation:Humans
    44. Louis CU, Savoldo B, Dotti G, Pule M, Yvon E, Myers GD, Rossig C, Russell HV, Diouf O, Liu E, Liu H, Wu MF, Gee AP, Mei Z, Rooney CM, Heslop HE, Brenner MK. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood. 2011 Dec 01; 118(23):6050-6. PMID: 21984804; PMCID: PMC3234664.
      Citations: 490     Fields:    Translation:HumansCellsCTClinical Trials
    45. Egler RA, Li Y, Dang TA, Peters TL, Leung E, Huang S, Russell HV, Liu H, Man TK. An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring. Proteomics Clin Appl. 2011 Oct; 5(9-10):532-41. PMID: 21833997; PMCID: PMC3685293.
      Citations: 7     Fields:    Translation:Humans
    46. Berg SL, Cairo MS, Russell H, Ayello J, Ingle AM, Lau H, Chen N, Adamson PC, Blaney SM. Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report. J Clin Oncol. 2011 Jan 20; 29(3):316-23. PMID: 21149673; PMCID: PMC3056465.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    47. Su JM, Li XN, Thompson P, Ou CN, Ingle AM, Russell H, Lau CC, Adamson PC, Blaney SM. Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report. Clin Cancer Res. 2011 Feb 01; 17(3):589-97. PMID: 21115653; PMCID: PMC3064523.
      Citations: 51     Fields:    Translation:HumansCellsCTClinical Trials
    48. Russell H, Shohet JM. Pediatric oncology: G-CSF counteracts chemotherapy toxicity in neuroblastoma. Nat Rev Clin Oncol. 2011 Jan; 8(1):6-8. PMID: 21102531.
      Citations: 4     Fields:    Translation:Humans
    49. Russell HV, Groshen SG, Ara T, DeClerck YA, Hawkins R, Jackson HA, Daldrup-Link HE, Marachelian A, Skerjanec A, Park JR, Katzenstein H, Matthay KK, Blaney SM, Villablanca JG. A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study. Pediatr Blood Cancer. 2011 Aug; 57(2):275-82. PMID: 21671363; PMCID: PMC3117015.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    50. Carlson P, Jefferies JL, Kearney D, Russell H. Refractory dilated cardiomyopathy associated with metastatic neuroblastoma. Pediatr Blood Cancer. 2010 Oct; 55(4):736-8. PMID: 20589652.
      Citations: 1     Fields:    Translation:Humans
    51. Vasudevan SA, Shang X, Shang X, Chang S, Ge N, Diaz-Miron JL, Russell HV, Hicks MJ, Ludwig AD, Wesson CL, Burlingame SM, Kim ES, Khan J, Yang J, Nuchtern JG. Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma. Mol Cancer Ther. 2009 Aug; 8(8):2478-89. PMID: 19671756; PMCID: PMC3618953.
      Citations: 7     Fields:    Translation:HumansCells
    52. Shang X, Burlingame SM, Okcu MF, Ge N, Russell HV, Egler RA, David RD, Vasudevan SA, Yang J, Nuchtern JG. Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma. Mol Cancer Ther. 2009 Aug; 8(8):2461-9. PMID: 19671766; PMCID: PMC3966113.
      Citations: 40     Fields:    Translation:HumansCells
    53. Russell H, Hicks MJ, Bertuch AA, Chintagumpala M. Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy. Pediatr Blood Cancer. 2009 Jul; 53(1):23-7. PMID: 19340853.
      Citations: 10     Fields:    Translation:Humans
    54. Ara T, Song L, Shimada H, Keshelava N, Russell HV, Metelitsa LS, Groshen SG, Seeger RC, DeClerck YA. Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells. Cancer Res. 2009 Jan 01; 69(1):329-37. PMID: 19118018; PMCID: PMC2761219.
      Citations: 88     Fields:    Translation:HumansAnimalsCells
    55. Pule MA, Savoldo B, Myers GD, Rossig C, Russell HV, Dotti G, Huls MH, Liu E, Gee AP, Mei Z, Yvon E, Weiss HL, Liu H, Rooney CM, Heslop HE, Brenner MK. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat Med. 2008 Nov; 14(11):1264-70. PMID: 18978797; PMCID: PMC2749734.
      Citations: 579     Fields:    Translation:HumansCells
    56. Egler RA, Burlingame SM, Nuchtern JG, Russell HV. Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma. Clin Cancer Res. 2008 Nov 01; 14(21):7028-34. PMID: 18980999; PMCID: PMC2613275.
      Citations: 28     Fields:    Translation:Humans
    57. Russell HV, Strother D, Mei Z, Rill D, Popek E, Biagi E, Yvon E, Brenner M, Rousseau R. A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete IL-2 in patients with high-risk neuroblastoma. J Immunother. 2008 Nov-Dec; 31(9):812-9. PMID: 18833006.
      Citations: 14     Fields:    Translation:HumansCellsCTClinical Trials
    58. Himes RW, Raijman I, Finegold MJ, Russell HV, Fishman DS. Diagnostic and therapeutic role of endoscopic retrograde cholangiopancreatography in biliary rhabdomyosarcoma. World J Gastroenterol. 2008 Aug 14; 14(30):4823-5. PMID: 18720547; PMCID: PMC2739348.
      Citations: 4     Fields:    Translation:Humans
    59. Plon SE, Pirics ML, Nuchtern J, Hicks J, Russell H, Agrawal S, Zbuk K, Eng C, Hegde M, Chin EL. Multiple tumors in a child with germ-line mutations in TP53 and PTEN. N Engl J Med. 2008 Jul 31; 359(5):537-9. PMID: 18669439.
      Citations: 3     Fields:    Translation:Humans
    60. Gay AN, Chang S, Rutland L, Yu L, Byeseda S, Naik-Mathuria B, Cass DL, Russell H, Olutoye OO. Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells: implications for disease-free survival of high-risk patients. J Pediatr Surg. 2008 May; 43(5):837-42. PMID: 18485949; PMCID: PMC2577882.
      Citations: 6     Fields:    Translation:HumansCells
    61. Louis CU, Paulino AC, Gottschalk S, Bertuch AA, Chintagumpala M, Heslop HE, Russell HV. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol. 2007 Jul; 29(7):500-5. PMID: 17609631.
      Citations: 7     Fields:    Translation:Humans
    62. De Bortoli M, Castellino RC, Skapura DG, Shen JJ, Su JM, Russell HV, Hicks MJ, Man TK, Kim JY. Patched haploinsufficient mouse rhabdomyosarcoma overexpress secreted phosphoprotein 1 and matrix metalloproteinases. Eur J Cancer. 2007 May; 43(8):1308-17. PMID: 17467979.
      Citations: 3     Fields:    Translation:HumansAnimals
    63. Russell HV, Strother D, Mei Z, Rill D, Popek E, Biagi E, Yvon E, Brenner M, Rousseau R. Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin. J Immunother. 2007 Feb-Mar; 30(2):227-33. PMID: 17471169.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    64. Vasudevan SA, Russell HV, Okcu MF, Burlingame SM, Liu ZJ, Yang J, Nuchtern JG. Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastoma. J Pediatr Surg. 2007 Jan; 42(1):148-52. PMID: 17208556.
      Citations: 7     Fields:    Translation:Humans
    65. Russell HV, Golding LA, Suell MN, Nuchtern JG, Strother DR. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma. Pediatr Blood Cancer. 2005 Dec; 45(7):916-9. PMID: 16078212.
      Citations: 3     Fields:    Translation:Humans
    66. Okcu MF, Wang RY, Bueso-Ramos C, Schober W, Weidner D, Andrassy R, Blakely M, Russell H, Ozkan A, Kuttesch J, Andreeff M, Chan KW, Ater J. Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow. Pediatr Blood Cancer. 2005 Nov; 45(6):787-95. PMID: 15929127.
      Citations: 2     Fields:    Translation:HumansCells
    67. Straathof KC, Bollard CM, Popat U, Huls MH, Lopez T, Morriss MC, Gresik MV, Gee AP, Russell HV, Brenner MK, Rooney CM, Heslop HE. Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes. Blood. 2005 Mar 01; 105(5):1898-904. PMID: 15542583.
      Citations: 128     Fields:    Translation:HumansCellsCTClinical Trials
    68. Russell HV, Hicks J, Okcu MF, Nuchtern JG. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. J Pediatr Surg. 2004 Oct; 39(10):1506-11. PMID: 15486895.
      Citations: 48     Fields:    Translation:Humans
    RUSSELL's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (313)
    Explore
    _
    Co-Authors (69)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _